Servicios de PI
Política
Cooperación
Conocimiento
Sobre la PI
34, chemin des Colombettes CH-1211 Ginebra 20, Suiza
Visite la OMPI | Contacto
La OMPI por dentro
Buscar Reiniciar
Consulta > Inglés > 2019 > Current
Guidelines to using evidence from research to support policymaking
This Guide elaborates on the best practices in conducting empirical studies in the intellectual property (IP) field. In so doing, it seeks to improve the credibility of studies, enhance transparency about what conclusions can and cannot be drawn from such studies, and encourage responsible use of studies by IP stakeholders.
Año de publicación: 2019
Pat-INFORMED - A global gateway to patent information about medicines
The Patent Information Initiative for Medicines (Pat-INFORMED) is an initiative of WIPO, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and 20 leading,innovative biopharmaceutical companies. The initiative is built upon the belief that the patent system stimulates innovation while making patent information available and accessible.
Urgent Innovation – Policies and Practices for Effective Response to Public Health Crises
Public health crises require urgent innovation, not only in research and development (R&D) but also in the delivery of therapies and diagnostics. What constitutes “urgency” and “innovation” in these contexts? How are priorities and targets determined? Who is best placed to deliver results? This edition of the Global Challenges in Focus series explores themes discussed at a recent Global Challenges Seminar on the policies and practices that facilitate effective responses to global health crises.
Guide to WIPO's services for country code top-level domain registries
This guide presents country code top-level domain (ccTLD) registry operators and national authorities with information on how to resolve third-party domain name disputes in a cost- and time-saving manner. It explains the main policy design features of a successful Alternative Dispute Resolution (ADR) system, and provides information on the WIPO-created Uniform Domain Name Dispute Resolution Policy (UDRP), including the possibility to tailor the UDRP for specific ccTLD requirements.
BVGH Partnership Hub - Mid-Year Report 2019
The consortium's objective is to establish partnerships that facilitate sharing of IP assets to advance the discovery and development of new drugs, vaccines, and diagnostics for NTDs, malaria, and tuberculosis.
BVGH Partnership Hub - Annual Report 2018
Green School's installation of SOURCE Hydropanels in Bali, Indonesia
Matchmaking Impact Stories
In 2018, Green School started looking for a way to produce clean drinking water for its campus on Bali, Indonesia. Thanks to a WIPO GREEN project, the school established collaboration with Zero Mass Water and brought sustainable potable water – generated from sunlight and air – to its students.
Guide to the International Patent Classification (2019)
.
Guide to the International Registration of Marks under the Madrid Agreement and the Madrid Protocol (2019)
This Guide is primarily intended for applicants and holders of international registrations of marks, as well as officials of the competent administrations of the Member States of the Madrid Union. It leads them through the various steps of the international registration procedure and explains the essential provisions of the Madrid Agreement, the Madrid Protocol and the Common Regulations.
WIPO Re:Search: Advancing Product Development for Neglected Infectious Diseases through Global Public-Private Partnerships
WIPO Re:Search Consortium unites public and private market forces to address neglected tropical diseases (NTDs), malaria, and tuberculosis (TB) through sharing of intellectual property across sectors and geographies. To date, WIPO Re:Search has catalyzed over 150 R&D collaborations and managed capacity-building fellowships for scientists across sub-Saharan Africa and other low- and middle-income regions. This publication highlights seven exciting collaborations that are advancing solutions to help over one billion people who suffer from NTDs, malaria, and TB.
